Canopus BioPharma Incorporated
233 Wilshire Boulevard
Suite 700
Santa Monica, CA 90401
United States
353-627-8674
版塊: Communication Services
行業: Advertising Agencies
全職員工:
高階主管
| 名稱 | 頭銜 | 支付 | 行使價 | 出生年份 |
|---|---|---|---|---|
| Mr. Patrick T. Prendergast | Chairman & CEO | 無 | 無 | 無 |
| Mr. Leo J. Prendergast | COO & Director | 無 | 無 | 無 |
| Mr. Andries J. Lategan B.Pharm, M.Sc, Ph.D. | Chief Scientific Officer | 無 | 無 | 無 |
| Ms. Elizabeth Shanahan B.Sc. (Hon) | Pres of Oncology Division | 無 | 無 | 無 |
截止 為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。
描述
Canopus BioPharma Incorporated, a pharmaceutical research company, provides pharmaceutical products and assay methods to patients suffering from infectious, cancer, and addiction diseases. It also provides antivirals, radiation protection products, oncology products, bio-barcode assays, camelidae blood products, and neutraceutricals. The company was founded in 1996 as Canopus Corporation and changed its name in 2007. Canopus BioPharma Incorporated is based in Santa Monica, California.
公司管治
截至 無 止，Canopus BioPharma Incorporated 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。
企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。
